{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:19:39Z","timestamp":1792297179696,"version":"4.4.0"},"posted":{"date-parts":[[2024,9,24]]},"group-title":"Genetic and Genomic Medicine","reference-count":73,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T00:00:00Z","timestamp":1727136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Genetics can inform biologically relevant drug development and repurposing which may improve patient care. Here, we leverage the genetics of psychiatric disorders to prioritize potential drug targets and compounds. We used the genome-wide association studies of four psychiatric disorders [attention deficit hyperactivity disorder (ADHD), bipolar disorder, depression, and schizophrenia] and genes encoding drug targets. We conducted drug enrichment analyses incorporating the novel and biologically specific GSA-MiXeR tool. We conducted multiple molecular trait analyses using large-scale transcriptomic and proteomic datasets sampled from brain and blood tissue. This included the novel use of the UK Biobank proteomic data for a proteome-wide association study of psychiatric disorders. With the accumulated evidence, we prioritize potential drug targets and compounds for each disorder. We reveal candidate drug targets associated with a single or multiple disorders and that implicate glutamate signalling. Drug prioritization indicated genetic support for psychotropic medications including several top ranked antipsychotics for schizophrenia. We also observed genetic support for commonly used psychotropics for psychiatric treatment (e.g., clozapine, duloxetine, and lithium). Revealed opportunities for drug repurposing included cholinergic drugs for ADHD, estrogen modulators for depression, and matrix metalloproteinases for ADHD and depression. Our findings indicate the genetic liability to schizophrenia is associated with reduced brain and blood expression of\n                  <jats:italic>CYP2D6,<\/jats:italic>\n                  a gene encoding a metabolizer of drugs and neurotransmitters, suggesting a genetic risk for poor drug response and altered neurotransmission. Our extensive analyses highlight the utility of genetics for informing drug development and repurposing for psychiatric disorders providing novel opportunities for improving patient outcomes.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Graphical Abstract<\/jats:title>\n                  <jats:p>Depicted is the series of analyses conducted to generate a list of prioritized drug targets and compounds. First pairings of genome-wide association study (GWAS) traits with drugs are generated using enrichment analyses. Next a series of molecular trait analyses are conducted to generate and rank list of potential drug targets for each GWAS trait. Finally, enrichment and molecular trait results are combined to generate a ranked list of prioritized drugs for each GWAS trait based on supporting genetic evidence. ADHD = Attention deficit hyperactivity disorder, BIP = Bipolar disorder, DEP = Depression, SCZ = Schizophrenia, DBP = Diastolic blood pressure, T2D = Type 2 diabetes, RNA = ribonucleic acid, XWAS = both transcriptome and proteome wide association studies, MR = Mendelian randomization, coloc = colocalization.<\/jats:p>\n                  <jats:fig id=\"ufig1\" position=\"float\" orientation=\"portrait\" fig-type=\"figure\">\n                    <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"24314069v2_ufig1\" position=\"float\" orientation=\"portrait\"\/>\n                  <\/jats:fig>\n                <\/jats:sec>","DOI":"10.1101\/2024.09.24.24314069","type":"posted-content","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T11:55:14Z","timestamp":1727178914000},"source":"Crossref","is-referenced-by-count":2,"title":["Leveraging the Genetics of Psychiatric Disorders to Prioritize Potential Drug Targets and Compounds"],"prefix":"10.64898","author":[{"given":"Nadine","family":"Parker","sequence":"first","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Koch","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"},{"name":"Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey A.","family":"Shadrin","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Fuhrer","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy F. L.","family":"Hindley","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"},{"name":"Department of Psychiatry, Lovisenberg Diaconal Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Stinson","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Jaholkowski","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markos","family":"Tesfaye","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"},{"name":"Department of Clinical Science, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders M.","family":"Dale","sequence":"additional","affiliation":[{"name":"Multimodal Imaging Laboratory, University of California San Diego, La Jolla, CA, USA"},{"name":"Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA,"},{"name":"Department of Neurosciences, University of California San Diego, La Jolla, CA, USA"},{"name":"Department of Radiology, University of California, San Diego, La Jolla, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Wingo","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Davis, Sacramento, CA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza P.","family":"Wingo","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of California, Davis, Sacramento, CA, USA"},{"name":"Division of Mental Health, VA Medical Center, Mather, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Frei","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"},{"name":"Department of Pharmacy, Section for Pharmacology and Pharmaceutical Biosciences, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin S.","family":"O\u2019Connell","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav B.","family":"Smeland","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[{"name":"Centre for Precision Psychiatry, University of Oslo and Oslo University Hospital, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026030703150846000_2024.09.24.24314069v2.1","doi-asserted-by":"crossref","unstructured":"Minikel EV , Painter JL , Dong CC , Nelson MR . Refining the impact of genetic evidence on clinical success. Nature. 2024:1\u20136.","DOI":"10.1101\/2023.06.23.23291765"},{"key":"2026030703150846000_2024.09.24.24314069v2.2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3314"},{"key":"2026030703150846000_2024.09.24.24314069v2.3","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20153"},{"key":"2026030703150846000_2024.09.24.24314069v2.4","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20204"},{"key":"2026030703150846000_2024.09.24.24314069v2.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3461"},{"key":"2026030703150846000_2024.09.24.24314069v2.6","doi-asserted-by":"crossref","unstructured":"Bell N , Uffelmann E , Walree E van , Leeuw C de , Posthuma D . Using genome-wide association results to identify drug repurposing candidates. 2022:2022.09.06.22279660.","DOI":"10.1101\/2022.09.06.22279660"},{"key":"2026030703150846000_2024.09.24.24314069v2.7","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00857-4"},{"key":"2026030703150846000_2024.09.24.24314069v2.8","unstructured":"O\u2019Connell KS , Koromina M , Veen T van der , Boltz T , David FS , Yang JM , et al. Genomics yields biological and phenotypic insights into bipolar disorder. 2024:2023.10.07.23296687."},{"key":"2026030703150846000_2024.09.24.24314069v2.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01771-1"},{"key":"2026030703150846000_2024.09.24.24314069v2.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-021-00387-z"},{"key":"2026030703150846000_2024.09.24.24314069v2.11","doi-asserted-by":"crossref","unstructured":"Grotzinger AD , Fuente J de la , Davies G , Nivard MG , Tucker-Drob EM . Transcriptome-wide and Stratified Genomic Structural Equation Modeling Identify Neurobiological Pathways Underlying General and Specific Cognitive Functions. 2021.","DOI":"10.1101\/2021.04.30.21256409"},{"key":"2026030703150846000_2024.09.24.24314069v2.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00832-6"},{"key":"2026030703150846000_2024.09.24.24314069v2.13","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbad100"},{"key":"2026030703150846000_2024.09.24.24314069v2.14","doi-asserted-by":"publisher","DOI":"10.1038\/s41386-022-01456-5"},{"key":"2026030703150846000_2024.09.24.24314069v2.15","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1038\/s41380-022-01507-9","article-title":"Identifying causal genes for depression via integration of the proteome and transcriptome from brain and blood","volume":"27","year":"2022","journal-title":"Mol Psychiatry"},{"key":"2026030703150846000_2024.09.24.24314069v2.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.08.015"},{"key":"2026030703150846000_2024.09.24.24314069v2.17","doi-asserted-by":"crossref","first-page":"100190","DOI":"10.1016\/j.xgen.2022.100190","article-title":"A practical guideline of genomics-driven drug discovery in the era of global biobank meta-analysis","volume":"2","year":"2022","journal-title":"Cell Genomics"},{"key":"2026030703150846000_2024.09.24.24314069v2.18","doi-asserted-by":"crossref","first-page":"100341","DOI":"10.1016\/j.xgen.2023.100341","article-title":"Multi-layered genetic approaches to identify approved drug targets","volume":"3","year":"2023","journal-title":"Cell Genomics"},{"key":"2026030703150846000_2024.09.24.24314069v2.19","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.ajhg.2022.07.011","article-title":"Genetics-informed precision treatment formulation in schizophrenia and bipolar disorder","volume":"109","year":"2022","journal-title":"The American Journal of Human Genetics"},{"key":"2026030703150846000_2024.09.24.24314069v2.20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1055"},{"key":"2026030703150846000_2024.09.24.24314069v2.21","doi-asserted-by":"crossref","first-page":"110637","DOI":"10.1016\/j.pnpbp.2022.110637","article-title":"Candidates for drug repurposing to address the cognitive symptoms in schizophrenia","volume":"120","year":"2023","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"key":"2026030703150846000_2024.09.24.24314069v2.22","doi-asserted-by":"publisher","DOI":"10.1038\/S41588-022-01285-8"},{"key":"2026030703150846000_2024.09.24.24314069v2.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02352-1"},{"key":"2026030703150846000_2024.09.24.24314069v2.24","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-022-04434-5"},{"key":"2026030703150846000_2024.09.24.24314069v2.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0205-x"},{"key":"2026030703150846000_2024.09.24.24314069v2.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01058-3"},{"key":"2026030703150846000_2024.09.24.24314069v2.27","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0303-9"},{"key":"2026030703150846000_2024.09.24.24314069v2.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-0637-y"},{"key":"2026030703150846000_2024.09.24.24314069v2.29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1040"},{"key":"2026030703150846000_2024.09.24.24314069v2.30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S2215-0366(23)00143-8","article-title":"The relationship between cannabis use, schizophrenia, and bipolar disorder: a genetically informed study","volume":"10","year":"2023","journal-title":"The Lancet Psychiatry"},{"key":"2026030703150846000_2024.09.24.24314069v2.31","unstructured":"Bipolar Disorder Working Group of the Psychiatric Genomics Consortium 23andMe Research Team, O\u2019Connell KS , Koromina M , Forstner AJ , McQuillin A , Florio AD , et al. Genetic diversity enhances gene discovery for bipolar disorder. 2023:2023.10.07.23296687."},{"key":"2026030703150846000_2024.09.24.24314069v2.32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004219"},{"key":"2026030703150846000_2024.09.24.24314069v2.33","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3506"},{"key":"2026030703150846000_2024.09.24.24314069v2.34","unstructured":"Gandal MJ , Zhang P , Hadjimichael E , Walker RL , Chen C , Liu S , et al. Transcriptome-wide isoform-level dysregulation in ASD, schizophrenia, and bipolar disorder. Science. 2018;362."},{"key":"2026030703150846000_2024.09.24.24314069v2.35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1262110"},{"key":"2026030703150846000_2024.09.24.24314069v2.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02509-y"},{"key":"2026030703150846000_2024.09.24.24314069v2.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-022-01051-w"},{"key":"2026030703150846000_2024.09.24.24314069v2.38","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408"},{"key":"2026030703150846000_2024.09.24.24314069v2.39","doi-asserted-by":"crossref","unstructured":"de Klein N , Tsai EA , Vochteloo M , Baird D , Huang Y , Chen C-Y , et al. Brain expression quantitative trait locus and network analyses reveal downstream effects and putative drivers for brain-related diseases. Nat Genet. 2023:1\u201312.","DOI":"10.1038\/s41588-023-01300-6"},{"key":"2026030703150846000_2024.09.24.24314069v2.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-020-00773-z"},{"key":"2026030703150846000_2024.09.24.24314069v2.41","doi-asserted-by":"publisher","DOI":"10.1177\/0022146515594631.Marriage"},{"key":"2026030703150846000_2024.09.24.24314069v2.42","doi-asserted-by":"publisher","DOI":"10.1038\/s41586023-06592-6"},{"key":"2026030703150846000_2024.09.24.24314069v2.43","doi-asserted-by":"crossref","first-page":"e1004383","DOI":"10.1371\/journal.pgen.1004383","article-title":"Bayesian Test for Colocalisation between Pairs of Genetic Association Studies Using Summary Statistics","volume":"10","year":"2014","journal-title":"PLOS Genetics"},{"key":"2026030703150846000_2024.09.24.24314069v2.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.10.049"},{"key":"2026030703150846000_2024.09.24.24314069v2.45","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty784"},{"key":"2026030703150846000_2024.09.24.24314069v2.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.11.020"},{"key":"2026030703150846000_2024.09.24.24314069v2.47","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/sbx148"},{"key":"2026030703150846000_2024.09.24.24314069v2.48","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0561-7"},{"key":"2026030703150846000_2024.09.24.24314069v2.49","doi-asserted-by":"crossref","unstructured":"Parker N , Cheng W , Hindley GFL , Parekh P , Shadrin AA , Maximov II , et al. Psychiatric disorders and brain white matter exhibit genetic overlap implicating developmental and neural cell biology. Mol Psychiatry. 2023:1\u20139.","DOI":"10.1038\/s41380-023-02264-z"},{"key":"2026030703150846000_2024.09.24.24314069v2.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.05.031"},{"key":"2026030703150846000_2024.09.24.24314069v2.51","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mp.4001551"},{"key":"2026030703150846000_2024.09.24.24314069v2.52","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-025-00667-6","article-title":"Schizophrenia","volume":"11","year":"2025","journal-title":"Nat Rev Dis Primers"},{"key":"2026030703150846000_2024.09.24.24314069v2.53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03819-3"},{"key":"2026030703150846000_2024.09.24.24314069v2.54","doi-asserted-by":"publisher","DOI":"10.1038\/S41588-025-02291-2"},{"key":"2026030703150846000_2024.09.24.24314069v2.55","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s40120-022-00392-2","article-title":"Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review","volume":"11","year":"2022","journal-title":"Neurol Ther"},{"key":"2026030703150846000_2024.09.24.24314069v2.56","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-014-0208-9"},{"key":"2026030703150846000_2024.09.24.24314069v2.57","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.15976"},{"key":"2026030703150846000_2024.09.24.24314069v2.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.12.002"},{"key":"2026030703150846000_2024.09.24.24314069v2.59","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.6.529"},{"key":"2026030703150846000_2024.09.24.24314069v2.60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03567-4"},{"key":"2026030703150846000_2024.09.24.24314069v2.61","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.psyneuen.2017.10.025","article-title":"Increased estrogen level can be associated with depression in males","volume":"87","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"2026030703150846000_2024.09.24.24314069v2.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2014.12.024"},{"key":"2026030703150846000_2024.09.24.24314069v2.63","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1146\/annurev-clinpsy-050718-095557","article-title":"Estrogen, Stress, and Depression: Cognitive and Biological Interactions","volume":"15","year":"2019","journal-title":"Annual Review of Clinical Psychology"},{"key":"2026030703150846000_2024.09.24.24314069v2.64","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01548.x"},{"key":"2026030703150846000_2024.09.24.24314069v2.65","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0675-y"},{"key":"2026030703150846000_2024.09.24.24314069v2.66","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ejphar.2013.12.025","article-title":"The endogenous substrates of brain CYP2D","volume":"724","year":"2014","journal-title":"European Journal of Pharmacology"},{"key":"2026030703150846000_2024.09.24.24314069v2.67","first-page":"1","article-title":"Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure","volume":"78","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"2026030703150846000_2024.09.24.24314069v2.68","doi-asserted-by":"publisher","DOI":"10.1002\/humu.20039"},{"key":"2026030703150846000_2024.09.24.24314069v2.69","first-page":"335","article-title":"The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients","volume":"10","year":"2000","journal-title":"Pharmacogenetics and Genomics"},{"key":"2026030703150846000_2024.09.24.24314069v2.70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/sj.npp.1395370","article-title":"The Role of Serotonin in Antipsychotic Drug Action","volume":"21","year":"1999","journal-title":"Neuropsychopharmacol"},{"key":"2026030703150846000_2024.09.24.24314069v2.71","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.86"},{"key":"2026030703150846000_2024.09.24.24314069v2.72","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbw114"},{"key":"2026030703150846000_2024.09.24.24314069v2.73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04558-1"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.09.24.24314069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:15:17Z","timestamp":1772882117000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2024.09.24.24314069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,24]]},"references-count":73,"URL":"https:\/\/doi.org\/10.1101\/2024.09.24.24314069","relation":{},"subject":[],"published":{"date-parts":[[2024,9,24]]},"subtype":"preprint"}}